Published in Science on May 21, 1999
Sialylation is essential for early development in mice. Proc Natl Acad Sci U S A (2002) 2.15
Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest (2007) 2.04
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat Chem Biol (2012) 1.70
Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med (2009) 1.57
Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol (2002) 1.55
Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun (2015) 1.50
Metabolic glycoengineering: sialic acid and beyond. Glycobiology (2009) 1.45
Hereditary inclusion body myopathy: a decade of progress. Biochim Biophys Acta (2009) 1.28
Functional characterization of wild-type and mutant human sialin. EMBO J (2004) 1.16
Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis. Mol Cell Proteomics (2012) 1.13
Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells. J Am Chem Soc (2008) 1.09
Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol (2007) 1.07
Photocrosslinking of glycoconjugates using metabolically incorporated diazirine-containing sugars. Nat Protoc (2009) 1.05
Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins. Am J Pathol (2005) 1.05
CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. J Immunol (2010) 1.04
Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy. Mol Genet Metab (2012) 0.99
A structural basis for the allosteric regulation of non-hydrolysing UDP-GlcNAc 2-epimerases. EMBO Rep (2008) 0.95
Reduced sialylation status in UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE)-deficient mice. Glycoconj J (2007) 0.95
Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. Hum Gene Ther (2011) 0.93
Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans. Glycobiology (2012) 0.93
The hereditary inclusion body myopathy enigma and its future therapy. Neurotherapeutics (2008) 0.92
Molecular physiology and pathophysiology of lysosomal membrane transporters. J Inherit Metab Dis (2008) 0.91
Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy. J Biol Chem (2011) 0.91
Biochemical characterization of human and murine isoforms of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE). Glycoconj J (2008) 0.89
Crystal structure of the N-acetylmannosamine kinase domain of GNE. PLoS One (2009) 0.88
The proteomic profile of hereditary inclusion body myopathy. PLoS One (2011) 0.88
Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid. J Biol Chem (2012) 0.88
Podocyte pathology and nephropathy - sphingolipids in glomerular diseases. Front Endocrinol (Lausanne) (2014) 0.87
Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle. J Clin Biochem Nutr (2010) 0.87
Metabolism of diazirine-modified N-acetylmannosamine analogues to photo-cross-linking sialosides. Bioconjug Chem (2011) 0.86
Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA). Brain (2009) 0.86
Sizing up sialic acid in glomerular disease. J Clin Invest (2007) 0.86
Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice. PLoS One (2012) 0.86
The Gne M712T mouse as a model for human glomerulopathy. Am J Pathol (2012) 0.85
UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis. Top Curr Chem (2015) 0.83
Crystal structures of N-acetylmannosamine kinase provide insights into enzyme activity and inhibition. J Biol Chem (2012) 0.83
Hereditary Inclusion Body Myopathy (HIBM2). Gene Regul Syst Bio (2009) 0.82
Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. PLoS One (2014) 0.81
Modified GM3 gangliosides produced by metabolic oligosaccharide engineering. Bioorg Med Chem Lett (2011) 0.81
Mass isotopomer analysis of metabolically labeled nucleotide sugars and N- and O-glycans for tracing nucleotide sugar metabolisms. Mol Cell Proteomics (2013) 0.81
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle. Acta Myol (2011) 0.81
Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clin Proteomics (2015) 0.80
Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamine. J Biol Chem (2012) 0.80
Domain-specific characteristics of the bifunctional key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Biochem J (2004) 0.80
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells. Oncotarget (2016) 0.78
A novel approach to decrease sialic acid expression in cells by a C-3-modified N-acetylmannosamine. J Biol Chem (2014) 0.78
Cellular metabolism of unnatural sialic acid precursors. Glycoconj J (2015) 0.78
Discovery of Novel Putative Inhibitors of UDP-GlcNAc 2-Epimerase as Potent Antibacterial Agents. ACS Med Chem Lett (2013) 0.77
The Interaction of UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) and Alpha-Actinin 2 Is Altered in GNE Myopathy M743T Mutant. Mol Neurobiol (2016) 0.77
Sialidases as regulators of bioengineered cellular surfaces. Glycobiology (2015) 0.77
A family with distal myopathy with rimmed vacuoles associated with thrombocytopenia. Neurol Sci (2014) 0.77
Enhanced Cross-Linking of Diazirine-Modified Sialylated Glycoproteins Enabled through Profiling of Sialidase Specificities. ACS Chem Biol (2015) 0.77
Non-specific accumulation of glycosphingolipids in GNE myopathy. J Inherit Metab Dis (2013) 0.76
Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2. Gene Regul Syst Bio (2009) 0.76
A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review. Ther Adv Neurol Disord (2010) 0.76
Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy. Biomark Med (2014) 0.76
VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer. Int J Oncol (2013) 0.76
Synthesis and cardiovascular protective effects of quercetin 7-O-sialic acid. J Cell Mol Med (2016) 0.76
Nationwide patient registry for GNE myopathy in Japan. Orphanet J Rare Dis (2014) 0.75
Congenital protein hypoglycosylation diseases. Appl Clin Genet (2012) 0.75
Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example. Biomaterials (2016) 0.75
Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: Secondary structures, expression profiles, and response to ManNAc therapy. Glycoconj J (2012) 0.75
Applying Acylated Fucose Analogues to Metabolic Glycoengineering. Bioengineering (Basel) (2015) 0.75
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem (1992) 3.48
Cathepsin L. A new proteinase from rat-liver lysosomes. Eur J Biochem (1977) 2.75
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol (1968) 2.47
A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods (2001) 2.15
A viral enhancer element specifically active in human haematopoietic cells. Nature (1985) 1.95
Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology (2001) 1.93
CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood (1998) 1.91
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer (2010) 1.89
A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. J Biol Chem (1997) 1.88
Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization. J Cell Biol (1997) 1.84
Metabolism of insulin and glucagon. Breakdown of radioiodinated insulin and glucagon in rat liver cell fractions. Eur J Biochem (1971) 1.74
Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther (1999) 1.73
Cathepsin H: an endoaminopeptidase from rat liver lysosomes. Acta Biol Med Ger (1977) 1.61
Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J Biol Chem (1992) 1.59
Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A (1984) 1.59
A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J (1988) 1.59
Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J Virol (1990) 1.52
Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles. Lancet (1993) 1.48
Physical association of moesin and CD46 as a receptor complex for measles virus. J Virol (1995) 1.48
On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death. Virchows Arch B Cell Pathol (1978) 1.46
Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br J Dermatol (2011) 1.45
Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology (1994) 1.44
CD13--not just a marker in leukemia typing. Immunol Today (1999) 1.41
Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J Biol Chem (1995) 1.40
Marked differences in Betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitis. Br J Dermatol (2011) 1.39
Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood (2000) 1.35
The appearance of D-galactosamine-induced hepatitis and generalized edema in adrenalectomized rats. Beitr Pathol (1975) 1.34
Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur J Biochem (2001) 1.32
Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ (1995) 1.32
Substrate specificity of the sialic acid biosynthetic pathway. Biochemistry (2001) 1.31
[Intracellular protein breakdown. VII. Cathepsin L and H; two new proteinases from rat liver lysosomes]. Acta Biol Med Ger (1976) 1.30
Galactan-binding antibodies. Diversity and structure of idiotypes. J Exp Med (1983) 1.30
Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol (1991) 1.29
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res (1993) 1.28
Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol (1994) 1.28
Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol (1998) 1.28
The secretion of serum protein and the synthesis of albumin and total protein in regenerating rat liver. J Biol Chem (1971) 1.26
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol (1992) 1.25
Molecular cloning and characterization of murine and human N-acetylglucosamine kinase. Eur J Biochem (2000) 1.25
Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp Cell Res (1988) 1.24
Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol (2002) 1.24
ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem (1991) 1.18
Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor. J Biol Chem (1998) 1.16
The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J Virol (1993) 1.14
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7). Vaccine (2004) 1.11
Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5'-leader/gag region. Biochem Biophys Res Commun (1990) 1.11
Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments. J Biol Chem (1999) 1.10
Protein degradation in the plasma membrane of regenerating liver and Morris hepatomas. Eur J Biochem (1978) 1.10
Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. Virology (1995) 1.09
Purification and characterization of N-acetylglucosamine kinase from rat liver--comparison with UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Eur J Biochem (1998) 1.09
Different half-lives of the carbohydrate and protein moieties of a 110,000-dalton glycoprotein isolated from plasma membranes of rat liver. Proc Natl Acad Sci U S A (1980) 1.09
Metabolism of insulin and glucagon. Glutathione-insulin transhydrogenase from microsomes of rat liver. Eur J Biochem (1973) 1.08
Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6. Arthritis Res Ther (2003) 1.08
Consequences of a subtle sialic acid modification on the murine polyomavirus receptor. J Virol (1997) 1.08
Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol Chem Hoppe Seyler (1985) 1.07
The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem Biophys Res Commun (1995) 1.07
Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell Immunol (2000) 1.06
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Lett (2010) 1.05
Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol (2008) 1.04
Moesin, and not the murine functional homologue (Crry/p65) of human membrane cofactor protein (CD46), is involved in the entry of measles virus (strain Edmonston) into susceptible murine cell lines. J Gen Virol (1995) 1.04
Biosynthesis of N-acetylneuraminic acid in Morris hepatomas. Eur J Biochem (1973) 1.04
Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats. Exp Mol Pathol (1970) 1.04
Two different cytoplasmic tails direct isoforms of the membrane cofactor protein (CD46) to the basolateral surface of Madin-Darby canine kidney cells. J Biol Chem (1996) 1.03
Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry. Histochemistry (1988) 1.03
Tat- and Rev-directed antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1: a temporal analysis. J Virol (1992) 1.02
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Int J Cancer (2000) 1.02
Characterization of a new human papillomavirus (HPV 41) from disseminated warts and detection of its DNA in some skin carcinomas. Int J Cancer (1988) 1.02
Cloning and sequencing of porcine moesin and radixin cDNA and identification of highly conserved domains. Biochim Biophys Acta (1993) 1.01
Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection. Nucleic Acids Res (1998) 1.01
Electrotransfection of human lymphoid and myeloid cell lines. Nucleic Acids Res (1988) 1.01
Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer (2013) 1.00
Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Biol Chem (2001) 1.00
Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology (1999) 1.00
Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells. J Biol Chem (1992) 0.99
IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol (2001) 0.99
Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J Exp Med (1993) 0.99
Half-life of N-acetylneuraminic acid in plasma membranes of rat liver and Morris hepatoma 7777. Cancer Res (1974) 0.98
kappa-Chain restriction in anti-galactan antibodies. J Immunol (1982) 0.98
Action of cathepsin L on the oxidized B-chain of bovine insulin. FEBS Lett (1980) 0.98
A selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulfonamide (H-89), inhibits phosphatidylcholine biosynthesis in HeLa cells. FEBS Lett (1992) 0.98
Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiology (1994) 0.98